Clinical trial
Oxaliplatin in Treating Women With Advanced or Metastatic Breast Cancer That Has…
NCT00006121 · European Organisation for Research and Treatment of Cancer - EORTC, Other · Terminated
Key facts
| NCT number | NCT00006121 |
|---|---|
| Title | Oxaliplatin in Treating Women With Advanced or Metastatic Breast Cancer That Has Not Responded to Previous Chemotherapy |
| Official title | Phase II Study of Oxaliplatin Single Agent in Patients With Metastatic Breast Cancer After Failure of Anthracycline/Taxane Based Chemotherapy |
| Lead sponsor | European Organisation for Research and Treatment of Cancer - EORTC, Other |
| Status | Terminated |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Breast Cancer |
| Intervention type | Drug |
| Interventions | oxaliplatin |
| Enrollment | 18 |
| Start date | May 1, 2000 |
| Primary completion | May 1, 2002 |
| First posted | Oct 8, 2003 |
| Last update posted | Jul 24, 2012 |
| Countries | Austria, Belgium, France, Germany, Israel, Slovenia, United Kingdom |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: